Cargando…

Regulatory Phenotype, PD-1 and TLR3 Expression in T Cells and Monocytes from HCV Patients Undergoing Antiviral Therapy: A Randomized Clinical Trial

BACKGROUND & AIMS: The cellular immunity has a profound impact on the status of hepatitis C virus (HCV) infection. However, the response of cellular immunity on the virological response in patients with antiviral treatment remains largely unclear. We aimed to clarify the response of peripheral T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Shan-shan, He, Huan, Kong, Ling-bo, Zhang, Yu-guo, Zhao, Su-xian, Wang, Rong-qi, Zheng, Huan-wei, Sun, Dian-xing, Nan, Yue-min, Yu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977904/ https://www.ncbi.nlm.nih.gov/pubmed/24709775 http://dx.doi.org/10.1371/journal.pone.0093620

Ejemplares similares

Tim-3 suppression combined with TLR3 activation enhances antiviral immune response in patients with chronic HCV infection
por: Nan, Yue-min, et al.
Publicado: (2016)

T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy
por: Auma, Ann W N, et al.
Publicado: (2021)

HCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral Responses
por: Zhang, Yuwei, et al.
Publicado: (2016)

PD-1 modulates Regulatory T cells and suppresses T cell responses in HCV-associated Lymphoma
por: Ni, Lei, et al.
Publicado: (2010)

Phenotypic characteristics of human monocytes undergoing transendothelial migration
por: Grisar, Johannes, et al.
Publicado: (2001)

NF-κB inhibition attenuates LPS-induced TLR4 activation in monocyte cells
por: Wan, Jian, et al.
Publicado: (2016)

CD14(+) monocytes and CD163(+) macrophages correlate with the severity of liver fibrosis in patients with chronic hepatitis C
por: Zhao, Su-Xian, et al.
Publicado: (2020)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Antiviral therapy of HCV in the cirrhotic and transplant candidate
por: Herrine, Steven K., et al.
Publicado: (2006)

Antiviral Therapy in HCV-infected Decompensated Cirrhotics
por: Danish, Fazal A., et al.
Publicado: (2010)

Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon
por: Mascia, Claudia, et al.
Publicado: (2017)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Cellular Activation and Intracellular HCV Load in Peripheral Blood Monocytes Isolated from HCV Monoinfected and HIV-HCV Coinfected Patients
por: Dichamp, Isabelle, et al.
Publicado: (2014)

Direct-acting antiviral treatments display excellent outcomes even in older HCV-infected patients at increased risk of fibrosis
por: Xia, Huan, et al.
Publicado: (2021)

Foxp3(+)Helios(+) regulatory T cells are associated with monocyte subsets and their PD-1 expression during acute HIV-1 infection
por: Liu, Lifeng, et al.
Publicado: (2019)

Higher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD Deficiency
por: Chao, Yuan-Chang, et al.
Publicado: (2008)

Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent
por: Kwon, Hyock Joo, et al.
Publicado: (2015)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

Cardiac Toxicity Associated with HCV Direct Antiviral Agents
por: Ucciferri, Claudio, et al.
Publicado: (2018)

Phenotypic and functional alterations of monocyte subsets with aging
por: Cao, Yu, et al.
Publicado: (2022)

Monocyte Activation in HIV/HCV Coinfection Correlates with Cognitive Impairment
por: Rempel, Hans, et al.
Publicado: (2013)

Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations
por: Sun, Hsin-Yun, et al.
Publicado: (2022)

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
por: Dold, L., et al.
Publicado: (2019)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Construction of a circRNA-Related ceRNA Prognostic Regulatory Network in Breast Cancer
por: Song, Huan, et al.
Publicado: (2020)

The Future of HCV Therapy: NS4B as an Antiviral Target
por: Dvory-Sobol, Hadas, et al.
Publicado: (2010)

Need to Face Liver Cirrhosis after HCV Cure with Antivirals
por: Soriano, Vicente, et al.
Publicado: (2017)

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents
por: Angeletti, Andrea, et al.
Publicado: (2019)

The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals
por: Chromy, David, et al.
Publicado: (2022)

Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease — a nationwide cohort study
por: Lin, Ming-Shyan, et al.
Publicado: (2017)

Contextualization Procedure and Modeling of Monocyte Specific TLR Signaling
por: Aurich, Maike K., et al.
Publicado: (2012)

Antiviral resistance in HCV strains isolated from Romanian patients with limited treatment options for chronic HCV infection
por: Streinu-Cercel, Anca, et al.
Publicado: (2014)

Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection
por: Casey, Julia L., et al.
Publicado: (2019)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Baseline Plasma Metabotype Correlates With Direct-Acting Antiviral Therapy Nonresponse for HCV in HIV–HCV Coinfected Patients
por: Tripathi, Gaurav, et al.
Publicado: (2022)

Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection
por: Pinchera, Biagio, et al.
Publicado: (2023)

Therapeutic Potential of TLR8 Agonist GS‐9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators
por: Amin, Oliver E., et al.
Publicado: (2021)

Regulatory role of the TLR4/JNK signaling pathway in sepsis-induced myocardial dysfunction
por: Chang, Chao, et al.
Publicado: (2021)

Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists
por: Lacerte, Patricia, et al.
Publicado: (2016)

Library construction of stereochemically diverse isomers of spirooliganin: their total synthesis and antiviral activity
por: Wang, Ru-Bing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s3gj2cs8akkh4i3c6avocn64rp